PGR logo Progressive Corporation +
Progressive Corporation
+

Progressive Corporation (PGR) Business News

Track Progressive Corporation in real time with a live news feed covering Progressive Corporation stock news, official press releases, company announcements, and an archive of historical Progressive Corporation news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

Progressive Reports April 2026 Results

GlobeNewsWire

8:17 AM | Wednesday | May 20, 2026

news photo
Loading...

MAYFIELD VILLAGE, OHIO, May 20, 2026 (GLOBE NEWSWIRE) -- The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended April 30, 2026:

Read full article redirect
8:17 AM | Wednesday | May 20, 2026

Progressive Reports April 2026 Results

GlobeNewsWire

MAYFIELD VILLAGE, OHIO, May 20, 2026 (GLOBE NEWSWIRE) -- The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended April 30, 2026:

Read full article arrow
News Thumbnail
7:00 AM | Tuesday | May 19, 2026

Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis

GlobeNewsWire

Favourable trends seen in stability of disability and clinically meaningful improvements in fatigue. BOSTON, May 19, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd.

Read full article arrow
News Thumbnail
2:14 PM | Monday | Apr 27, 2026

Progressive Announces Investor Relations Call

GlobeNewsWire

MAYFIELD VILLAGE, OHIO, April 27, 2026 (GLOBE NEWSWIRE) -- As previously announced, The Progressive Corporation (NYSE: PGR) will host an Investor Relations conference call on Tuesday, May 5, 2026, beginning at 9:30 a.m. eastern time. This quarterly call, which will consist of both a conference call and audio-only webcast, is scheduled to last 60 minutes and will consist of a question-and-answer session with Tricia Griffith, our CEO, and John Sauerland, our CFO. Call-in participants will be able to ask questions via phone, however, webcast participants will not be able to submit questions online.

Read full article arrow
News Thumbnail
8:24 AM | Wednesday | Apr 15, 2026

Progressive Reports March 2026 Results

GlobeNewsWire

MAYFIELD VILLAGE, OHIO, April 15, 2026 (GLOBE NEWSWIRE) -- The Progressive Corporation (NYSE:PGR) today reported the following results for the month and quarter ended March 31, 2026:

Read full article arrow
News Thumbnail
12:17 PM | Friday | Mar 27, 2026

AM Best Assigns Issue Credit Ratings to The Progressive Corporation's Senior Unsecured Notes

Business Wire

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IR) of “a” (Excellent) to the $500 million, 4.60% senior unsecured notes, due 2031, and $1 billion, 5.15% senior unsecured notes, due 2036, issued by The Progressive Corporation (Progressive) (Mayfield Village, OH) [NYSE: PGR].
The outlook assigned to these Credit Ratings (ratings) is stable. The assigned Long-Term IRs consider the rating profiles of Progressive's insurance subsidiaries, as well as th.

Read full article arrow
News Thumbnail
8:18 AM | Wednesday | Mar 18, 2026

Progressive Reports February 2026 Results

GlobeNewsWire

MAYFIELD VILLAGE, OHIO, March 18, 2026 (GLOBE NEWSWIRE) -- The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended February 28, 2026:

Read full article arrow
News Thumbnail
10:47 AM | Monday | Mar 9, 2026

Progressive Announces Quarterly Common Share Dividend

GlobeNewsWire

MAYFIELD VILLAGE, OHIO, March 09, 2026 (GLOBE NEWSWIRE) -- On March 6, 2026, the Board of Directors of The Progressive Corporation (NYSE:PGR) declared a $0.10 per common share dividend, payable April 10, 2026, to shareholders of record at the close of business on April 2, 2026.

Read full article arrow
News Thumbnail
1:10 AM | Monday | Mar 2, 2026

Genentech's Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)

Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the pivotal Phase III study (FENhance 1) of fenebrutinib in RMS met its primary endpoint, showing clinically meaningful and statistically significant results. The study demonstrated that fenebrutinib, an investigational Bruton's tyrosine kinase (BTK) inhibitor, markedly reduced the annualized relapse rate (ARR) by 51% compared to teriflunomide over a period of.

Read full article arrow
News Thumbnail